MannKind Q1 Afrezza sales up 184%

|About: MannKind Corporation (MNKD)|By:, SA News Editor

MannKind (NASDAQ:MNKD) Q1 results ($M): Afrezza sales: 3.4 (+184.4%).

Net loss: (30.4) (-86.5%); loss/share: (0.25) (-47.1%); cash utilization: (21.7) (-355.3%).

Revenue recognition standard changed to wholesaler sales instead of estimated sales to patients. $3.4M in previously deferred revenue (inventory in sales channels) reduced to zero and recognized as sales.

Subscribe for full text news in your inbox